LicenseTheData.comA field guide to business-data licensing
Home/Comparisons

Public evidence · 13 October 2026

Protege vs Turing Project Lazarus

Specialist licensing meets direct licensing. Neither advertised amounts nor a public seller route establish what your business will receive.

Jump to the terms ledger ↓

Research comparison; limited public terms. Pair-level evidence and scenario review is pending. Published fields alone do not meet our indexing threshold. This page is noindex and absent from the sitemap, not a negative verdict.

The terms ledger.

Headquarters or contact location is not seller eligibility. Response, acceptance and payout stages are not interchangeable.

Published descriptions and unresolved contract terms
CriterionProtegeTuring Project Lazarus
Operating recordsPublished
Healthcare, video, audio/speech, spatial/physical and other domains; generic CRM/SOP archives not explicitly enumerated
Source ↗
Published
Communications, tickets, wikis, databases and code; code not required and not bought alone
Source ↗
Company eligibilityPublished
Typically owns outright or controls broad global/all-media rights; quality and opportunity-specific qualification.
Source ↗
Published
Any company with real operating history and an authorized representative; operating, winding-down or closed.
Source ↗
Seller geographyUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Published
Most regions; strongest demand US/UK/Canada/EU; export restrictions apply.
Source ↗
Published compensationProvider claim
Negotiated revenue share. Gradient Health seven-figure revenue is a provider-hosted specialist case, not an ordinary business rate.
Source ↗
Provider claim
Single payout up to $1M; USD context; not recurring royalties or a guaranteed offer.
Source ↗
Fees & net proceedsUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Timeline & payment triggerProvider claim
Active opportunities often fulfilled under a month; fulfillment is not seller payment timing.
Source ↗
Provider claim
Intake call within one business day; valuation usually within a week of access. Neither is a payout deadline.
Source ↗
Preparation & seller effortPublished
Discovery → revenue-share agreement → curate/QA/mask → qualified deal → revenue-share payment.
Source ↗
Published
NDA → intake → representative sampling/valuation → one contract.
Source ↗
Ownership & permitted usePublished
Retains ownership; limited defined AI training/fine-tuning/evaluation/benchmarking rights; no public exhibition/redistribution/entertainment use.
Source ↗
Published
Retains underlying ownership; defined rights to prepared record.
Source ↗
Privacy & approvalProvider claim
Identifier removal and jurisdiction-specific workflows; optional anonymization/voice modification. Media FAQ is not a universal operating-data contract.
Source ↗
Provider claim
Named team, scoped access, air-gapped processing; personal data/secrets removed before model use. SOC 2 Type II claimed.
Source ↗
ExclusivityUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Retention & deletionUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
HQ / published contactPublished
Published contact: New York, NY, US; not independently verified operational HQ.
Source ↗
Unknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Operating records

ProtegePublished
Healthcare, video, audio/speech, spatial/physical and other domains; generic CRM/SOP archives not explicitly enumerated
Source ↗
Turing Project LazarusPublished
Communications, tickets, wikis, databases and code; code not required and not bought alone
Source ↗

Company eligibility

ProtegePublished
Typically owns outright or controls broad global/all-media rights; quality and opportunity-specific qualification.
Source ↗
Turing Project LazarusPublished
Any company with real operating history and an authorized representative; operating, winding-down or closed.
Source ↗

Seller geography

ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Turing Project LazarusPublished
Most regions; strongest demand US/UK/Canada/EU; export restrictions apply.
Source ↗

Published compensation

ProtegeProvider claim
Negotiated revenue share. Gradient Health seven-figure revenue is a provider-hosted specialist case, not an ordinary business rate.
Source ↗
Turing Project LazarusProvider claim
Single payout up to $1M; USD context; not recurring royalties or a guaranteed offer.
Source ↗

Fees & net proceeds

ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Timeline & payment trigger

ProtegeProvider claim
Active opportunities often fulfilled under a month; fulfillment is not seller payment timing.
Source ↗
Turing Project LazarusProvider claim
Intake call within one business day; valuation usually within a week of access. Neither is a payout deadline.
Source ↗

Preparation & seller effort

ProtegePublished
Discovery → revenue-share agreement → curate/QA/mask → qualified deal → revenue-share payment.
Source ↗
Turing Project LazarusPublished
NDA → intake → representative sampling/valuation → one contract.
Source ↗

Ownership & permitted use

ProtegePublished
Retains ownership; limited defined AI training/fine-tuning/evaluation/benchmarking rights; no public exhibition/redistribution/entertainment use.
Source ↗
Turing Project LazarusPublished
Retains underlying ownership; defined rights to prepared record.
Source ↗

Privacy & approval

ProtegeProvider claim
Identifier removal and jurisdiction-specific workflows; optional anonymization/voice modification. Media FAQ is not a universal operating-data contract.
Source ↗
Turing Project LazarusProvider claim
Named team, scoped access, air-gapped processing; personal data/secrets removed before model use. SOC 2 Type II claimed.
Source ↗

Exclusivity

ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Retention & deletion

ProtegeUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

HQ / published contact

ProtegePublished
Published contact: New York, NY, US; not independently verified operational HQ.
Source ↗
Turing Project LazarusUnknown
Not published / not established
Not established in inspected sources. Ask for the actual agreement; unknown does not mean free, unrestricted or accepted.

Which difference matters to your company?

Rights fit

For specialist healthcare or media rights, Protege's published categories and Gradient Health case are more relevant than ordinary CRM exports. Turing Project Lazarus lists Communications, tickets, wikis, databases and code; code not required and not bought alone. Do not extrapolate specialist case revenue to a small operating business.

Protege: source 1 ↗ source 2 ↗ source 3 ↗ Turing Project Lazarus: source 1 ↗ Public descriptions, not tested seller outcomes.

Data fit

For your existing records, start with category fit: Protege lists Healthcare, video, audio/speech, spatial/physical and other domains; generic CRM/SOP archives not explicitly enumerated; Turing Project Lazarus lists Communications, tickets, wikis, databases and code; code not required and not bought alone. Ask each which subset has active demand before preparing exports.

Protege: source 1 ↗ source 2 ↗ source 3 ↗ Turing Project Lazarus: source 1 ↗ Public descriptions, not tested seller outcomes.

Payment trigger

Protege: Active opportunities often fulfilled under a month; fulfillment is not seller payment timing. Turing Project Lazarus: Intake call within one business day; valuation usually within a week of access. Neither is a payout deadline. These clocks measure different stages, not equivalent payout deadlines; ask for a written acceptance-to-payment interval.

Protege: source 1 ↗ source 2 ↗ source 3 ↗ Turing Project Lazarus: source 1 ↗ Public descriptions, not tested seller outcomes.

Shared diligence, not shared guarantees.

Both routes need lawful rights to the material. Removing names does not remove confidentiality obligations or re-identification risk. Require sample approval, buyer-use restrictions, precise payment triggers and downstream retention/deletion terms.

Seller-outcome evidence

Protege: Gradient Health seller-hosted announcement corroborates partnership and imaging supply, not revenue. Provider-hosted case claims seven-figure revenue; no independently audited receipt.

Turing Project Lazarus: No independently audited operating-business payout established in this research. Provider cases and partnership confirmations do not establish a typical seller outcome.

Put two routes side by side.

Choose two different providers. No income ranking.

Sources & unknowns.

Source claims were inspected on 13 October 2026. No intake was submitted or transaction tested. Unknowns are not zero fees, universal eligibility or unrestricted rights.

Read the evidence and indexing methodology →